Skip to main content
The Journal of Headache and Pain logoLink to The Journal of Headache and Pain
. 2015 May 12;16:43. doi: 10.1186/s10194-015-0527-3

Hemodynamic characteristics of high-altitude headache following acute high altitude exposure at 3700 m in young Chinese men

Shi-Zhu Bian 1,2, Jun Jin 1,2, Qian-Ning Li 3, Jie Yu 1,2, Cai-Fa Tang 3, Rong-Sheng Rao 4, Shi-Yong Yu 1,2, Xiao-Hui Zhao 1,2, Jun Qin 1,2, Lan Huang 1,2,
PMCID: PMC4431987  PMID: 25968101

Abstract

Background

This study aimed to identify the systemic and cerebral hemodynamic characteristics and their roles in high-altitude headache (HAH) among young Chinese men following acute exposure.

Methods

The subjects (n = 385) were recruited in June and July of 2012. They completed case report form questionnaires, as well as heart rate (HR), blood pressure, echocardiogram and transcranial Doppler examinations at 3700 m following a two-hour plane flight. A subgroup of 129 participants was examined at two altitudes (500 and 3700 m).

Results

HAH was characterized by increased HR and cardiac output (CO) and lower saturation pulse oxygen (SpO2) (all p < 0.05). The change in tricuspid regurgitation was also different between the HAH positive (HAH+) and HAH negative (HAH-) subjects. Furthermore, the HAH+ subjects exhibited faster mean (Vm), systolic (Vs) and diastolic (Vd) velocities in the basilar artery (BA; all p < 0.05) and a faster Vd ( 25.96 ± 4.97 cm/s vs. 24.76 ± 4.76 cm/s, p = 0.045) in the left vertebral artery (VA). The bilateral VA asymmetry was also significantly different between the two groups. The pulsatility index (PI) and resistance index (RI) of left VA were lower in the HAH subjects (p < 0.05) and were negatively correlated with HAH (p < 0.05). Baseline CO and Vm in left VA (or right MCA in different regressions) were independent predictors for HAH, whereas CO/HR and ΔVd (Vd difference between bilateral VAs) were independent risk factors for HAH at 3700 m.

Conclusions

HAH was characterized, in part, by increased systemic hemodynamics and posterior cerebral circulation, which was reflected by the BA and left VA velocities, and lower arterial resistance and compliance. Furthermore, baseline CO and Vm in left VA or right MCA at sea level were independent predictors for HAH, whilst bilateral VA asymmetry may contribute to the development of HAH at high altitude.

Electronic supplementary material

The online version of this article (doi:10.1186/s10194-015-0527-3) contains supplementary material, which is available to authorized users.

Keywords: Systemic circulation, Cerebral circulation, Hemodynamic characteristics, High-altitude headache, Acute exposure

Background

High-altitude headache (HAH) is the primary critical complaint after high altitude exposure [1]. It is defined as a headache that occurs within 24 hours after ascending to 2500 m or higher [2]. HAH affects tourists’ and labor workers’ daily life and work due to its high incidence and discomfort experience [3]. HAH has also been defined as the primary symptom in diagnosis of acute mountain sickness [4].

Over the past several decades, epidemiology, clinical characteristics, risk factors, prevention and treatment aspects of HAH have been systematically studied in mountaineers [5, 2, 6, 7]. Clinical characteristics studies have showed that HAH presents as a sudden attack of migraine that is accompanied by nausea [6]. Previous studies have demonstrated that increased heart rate (HR) and self-anxiety scores, lower saturation pulse oxygen (SpO2) and a history of primary headache are all independent risk factors for HAH [8, 9]. Though oxygen inhalation, acetaminophen and aspirin have been used to treat HAH, the effects are quite often inconsistent [10, 11]. Despite accumulating evidence regarding HAH and related issues, the underlying mechanisms remain elusive [12, 13, 1].

HAH exhibits an impulsivity property [14], which may be related to the hemodynamics (or blood flow in artery) of patients. While most previous studies have focused on the risk factors and epidemiology of HAH, few of them give proper attentions to the hemodynamic characteristics of HAH [8, 9, 7]. Furthermore, most of these studies have been conducted in mountaineers, which may not reflect representative properties of HAH [5, 9, 12].

To the best of our knowledge, the hemodynamic characteristics of and their roles in HAH has not been fully uncovered. Thus, we postulate that hemodynamics especially cerebral hemodynamic parameters are related HAH and they may be predictors for HAH. Therefore, we performed this large sample size cohort study to explore the hemodynamic characteristics of HAH via examinations of the systemic and cerebral hemodynamic parameters using echocardiogram and transcranial Doppler sonography, respectively, following acute high altitude exposure (within 24 h after arrival at 3700 m) to facilitate our understanding of the disease process and provide insight into the specific phenotypes associated with the disease course.

Methods

Participants and procedures

Participants

Three hundred eighty-five participants were recruited in June and July of 2012 according to specific inclusion and exclusion criteria. The inclusion criteria were as follows: healthy males between the ages of 18 and 60 years who had no high-altitude exposure in recent two years. Individuals with any of the following conditions were excluded: neuropsychosis, cerebrovascular diseases, cardiovascular diseases, respiratory diseases, malignant tumors and liver or kidney disorders.

The study was reviewed and approved by the Ethics Committee of Xinqiao Hospital of Third Military Medical University. The study was thoroughly explained to all subjects who agreed to participate, and all volunteers signed informed consent forms prior to study participation.

Procedures

The subjects were transported to an altitude of 3700 m by plane over two hours of travel in June and July of 2012. None of the subjects drinks coffee regularly. The coffee, tea, and other caffeine-containing drinks as well as alcohol were avoided before the examinations. Baseline measurements of systemic and cerebral hemodynamic parameters were examined one week prior to the departure at sea level (Chengdu, 500 m) in a subgroup of 129 participants. The participants will receive regular training after a three days’ rest. They did the daily life activities and avoided any heavy exercises or physical labor in the first 72 hours at 3700 m. The field trials were performed within 18 to 24 hours after their arrivals at 3700 m. Structured case report questionnaires were used to record the subjects’ demographic information (i.e., age, body mass index (BMI), smoking and alcohol consumption), primary headache history [None of them takes medication regularly due to primary headache. However, severe headache (HAH) subjects were treated with NSAIDs or Sanlietong (Taiji medicine, Xi’an, China) as necessary at 3700 m] and HAH symptoms (0 = no headache; 1 = mild headache; 2 = moderate headache; 3 = severe headache).

Measurements of systemic hemodynamic parameters

The subjects’ systolic blood pressure (SBP), diastolic blood pressure (DBP), HR and SpO2 were measured using a sphygmomanometer (HEM-6200, OMRON, China) and a pulse oximeter (NONIN-9550, Nonin Onyx, USA) after the subjects had sat at rest for 30 min. Each subject received an echocardiogram examination (ultrasonography system, CX50, Philips, USA) that involved measurements of the end-diastolic internal diameters of the left atrium (LA), left ventricle (LV), right atrium (RA), right ventricle (RV) and pulmonary artery (PA), in addition to the stroke volume (SV), cardiac output (CO) and ejection fraction (EF).

Measurements of cerebral hemodynamic parameters

The examinations at both altitudes were performed in the morning after an overnight fast and caffeine containing drinks were avoided.

Transcranial Doppler sonography examinations were performed by the same technician using an ultrasonography system with a 2 Hz probe (EME TC2021-III, NICOLET, USA). For each subject, the following parameters were recorded: the mean velocity (Vm), systolic velocity (Vs), diastolic velocity (Vd), pulsatility index (PI) and resistance index (RI). These measurements were taken in the bilateral middle cerebral artery (MCA) for anterior circulation and in the vertebral artery (VA) and basilar artery (BA) for posterior circulation.

The asymmetry of the MCA and VA was calculated as ΔV = left velocity - right velocity for each lateral MCA or VA, whereas the asymmetry index (AI) was calculated as AI = ΔV/ [(left Vm + right Vm)/2]. The cerebrovascular conductance index was calculated as the Vm_MCA/mean arterial blood pressure.

Statistical analysis

The case report forms were excluded if the demographic information was not completed, the velocity could not be identified at the depths previously described or the systemic hemodynamic parameters were not measured.

The normally distributed measurement variables (age, BMI, SBP, DBP, SpO2, HR, echocardiography parameters and velocities, PIs and RIs of the BA, MCAs and VAs) were expressed as the mean ± standard deviation (SD). The non-normally distributed variables were presented as the medians (interquartile range). The enumerated data are expressed as the rate of occurrence (%).

The normally distributed variables for the systemic and cerebral circulation measurements were compared using a paired Student’s t-test between the 500 and 3700 m altitudes and were analyzed using an independent samples t-test between the HAH positive (HAH+) and HAH negative (HAH-) groups at both altitudes. The asymmetries, AIs and tricuspid regurgitation measurements were compared using a Mann–Whitney U test. The relationships between HAH and the previously described parameters at 500 m and 3700 m were analyzed using Spearman’s correlations. Variables with a p < 0.05 in correlation analyses or significant difference between HAH+ and HAH- groups were included in univariate logistic regression. Adjusted logistic analyses were used to identify independent predictors or risk factors for HAH after univariate logistic regression (Fig 1). Variables with colinearity were analyzed in different models (adjusted by primary variables or calculated variables respectively) to reduce the bias.

Fig. 1.

Fig. 1

The fluidogram of the statistical analysis

The statistical analyses were performed using SPSS 19.0 software for Windows. P ≤ 0.05 was considered statistically significant. Statisticians from Third Military Medical University were consulted regarding the statistical methods and results.

Results

Clinical characteristics of the subjects

Three hundred eighty-five subjects received both echocardiography and transcranial Doppler examinations at 3700 m of elevation (363 subjects had completely valid transcranial Doppler and echocardiography parameters). Baseline measurements at 500 m were also recorded among 129 individuals. The subjects in this study were characterized by a mean age of 23.35 ± 4.37 years and a mean BMI of 21.81 ± 2.50 kg/m2. The ethnicity of the population was primarily Han Chinese (83.2%). Overall, in our study, the incidence of HAH following acute exposure to 3700 m was 75.2% (273 of 363).

Alterations in systemic and cerebral hemodynamics

Both systemic and cerebral circulations were dramatically altered following acute exposure to high altitude from sea level. However, the blood pressure parameters, including the SBP, DBP, pulse pressure and mean arterial blood pressure, did not significantly increase after the acute exposure. The SpO2 decreased from 98.34 ± 1.06% to 88.72 ± 2.71% (p < 0.001). The LA, RA and RV all significantly decreased (all p < 0.001). However, the EF and CO significantly increased, as well as the velocity in the bilateral MCAs. In VAs and BA, the Vd exhibited a significant increase. However, the VAs asymmetries did not dramatically change. The changes in the hemodynamic parameters are summarized in Table 1.

Table 1.

Alterations in systemic and cerebral hemodynamics (N = 129)

Sea level 3700 m p value
Systemic hemodynamics
SBP 116.32 ± 15.24 115.84 ± 11.84 0.782
DBP 74.65 ± 10.93 76.24 ± 9.40 0.156
ΔBP 41.67 ± 11.71 39.61 ± 8.05 0.131
MAP 88.54 ± 11.25 89.44 ± 9.55 0.444
HR 63.58 ± 10.19 83.98 ± 11.90 <0.001**
SpO2 98.34 ± 1.06 88.72 ± 2.71 <0.001**
LA 30.91 ± 1.73 30.00 ± 1.92 <0.001**
LV 46.47 ± 2.45 46.15 ± 2.04 0.184
RA 35.70 ± 2.23 34.21 ± 2.15 <0.001**
RV 35.49 ± 2.08 33.72 ± 2.42 <0.001**
PA 20.24 ± 1.60 19.92 ± 1.60 0.097
EF 62.94 ± 5.49 66.56 ± 3.92 <0.001**
SV 65.24 ± 12.22 67.30 ± 8.31 0.088
CO 4.16 ± 0.95 5.32 ± 1.09 <0.001**
Tricuspid regurgitation 0.500 (1.00) 0.500(0.500) 0.885
Cerebral hemodynamics
Left side MCA
Vm 62.08 ± 10.39 65.79 ± 11.78 <0.001**
Vs 95.95 ± 14.60 99.80 ± 15.93 0.002**
Vd 42.69 ± 7.91 46.47 ± 9.07 <0.001**
PI 0.867 ± 0.133 0.817 ± 0.133 <0.001**
RI 0.554 ± 0.048 0.534 ± 0.048 <0.001**
Left side VA
Vm_ 32.77 ± 5.14 35.20 ± 5.83 <0.001**
Vs_ 50.70 ± 7.50 51.57 ± 7.91 0.233
Vd_ 21.91 ± 4.095 24.82 ± 4.86 <0.001**
PI 0.895 ± 0.181 0.770 ± 0.168 <0.001**
RI 0.570 ± 0.067 0.516 ± 0.061 <0.001**
Right side MCA
Vm 58.79 ± 10.18 63.25 ± 11.58 <0.001**
Vs 90.50 ± 14.18 94.71 ± 15.01 <0.001**
Vd 40.35 ± 7.49 44.55 ± 9.04 <0.001**
PI 0.864 ± 0.150 0.804 ± 0.130 <0.001**
RI 0.556 ± 0.055 0.530 ± 0.050 0.293
Right side VA
Vm 34.33 ± 4.77 36.47 ± 5.73 <0.001**
Vs 50.60 ± 6.55 51.78 ± 7.83 0.058
Vd 23.24 ± 4.12 25.90 ± 4.55 <0.001**
PI 0.808 ± 0.162 0.715 ± 0.117 <0.001**
RI 0.539 ± 0.061 0.499 ± 0.048 <0.001**
BA
Vm 39.66 ± 7.75 41.85 ± 9.58 0.002**
Vs 67.93 ± 13.57 66.19 ± 13.46 0.117
Vd 25.07 ± 5.85 28.59 ± 7.71 <0.001**
PI 1.093 ± 0.251 0.920 ± 0.220 <0.001**
RI 0.627 ± 0.068 0.567 ± 0.073 <0.001**
Asymmetry of the bilateral VAs
ΔVs 0.0 (11.0) 0.0 (12.0) 0.645
ΔVd −1.0 (6.0) −1.0 (6.0) 0.623
ΔVm −1.0 (7.0) −2.0 (8.0) 0.529
AI% −3.5 (20.2) −2.9 (18.1) 0.190
Conduction
CVCi 0.695 ± 0.145 0.730 ± 0.149 0.011*

BA: basilar artery; CO: cardiac output; CVCi : cerebrovascular conductance index; DBP: diastolic blood pressure; EF: ejection fraction; HAH: high-altitude headache; HAH+: HAH positive or with HAH; HAH-: HAH negative or without HAH;HR: heart rate; LA: end-diastolic internal diameters of left atrium; LV: end-diastolic internal diameters of left ventricle; MCA: middle cerebral artery; PA: end-diastolic internal diameters of pulmonary artery; PI: pulsatility index; RA: end-diastolic internal diameters of right atrium; RI: resistance index; RV: end-diastolic internal diameters of right ventricle; SBP: systolic blood pressure;SpO2: saturation pulse oxygen; SV: stroke volume; VA: vertebral artery; Vs: systolic velocity; Vd: diastolic velocity; Vm: mean velocity;ΔVs: difference in systolic velocity between bilateral isonym cerebral arteries; ΔVd: difference in diastolic velocity between bilateral isonym cerebral arteries;ΔVm: Difference in mean velocity between bilateral isonym cerebral arteries. Cerebrovascular conductance index (CVCi) = Vm_MCA/MAP

#: N = 129;

*p is 0.05 or less, **p is 0.01 or less

Most of the cerebral hemodynamic parameters altered dramatically from sea level to 3700 m and systemic hemodynamic parameters altered dramatically in part

Clinical and hemodynamic characteristics of HAH at 3700 m

Only age (p = 0.044) was significantly higher in the HAH+ group as compared with the HAH- group regarding demographic data. The HAH+ patients were characterized by increased HR (87.96 ± 13.02 vs. 84.41 ± 13.11 beats per min, p = 0.026) and decreased SpO2 (87.94 ± 3.19 vs. 88.70 ± 2.98%, p = 0.048). Regarding blood pressure, there was no significant difference between the HAH+ and HAH- groups in the SBP, DBP, pulse pressure or mean arterial blood pressure. Although the LA, LV, RA, RV, PA, EF, SV and tricuspid regurgitation were not significantly different in the HAH+ subjects compared with the HAH- subjects (all p > 0.05), the CO was significantly increased in the HAH+ group (p = 0.001).

Anterior circulation, which was assessed via measurements of velocities in MCAs, was similar in the HAH+ and HAH- groups in bilateral MCAs (all p > 0.05). The PIs and RIs in the right and left MCA were not different between the two groups. For posterior circulation, the velocities in BA, including Vs (65.46 ± 11.54 vs. 68.81 ± 14.84, p = 0.028), Vd (28.61 ± 7.46 vs. 30.47 ± 7.52, p = 0.042) and Vm (41.42 ± 8.64 vs. 44.18 ± 9.74, p = 0.017), were significantly different in the HAH- group as compared with the HAH+ group, respectively. Similar to the MCA, the PI (p = 0.151) and RI (p = 0.292) of the BA were not significantly different between the HAH+ and HAH- groups. Furthermore, the Vd in left VA was significantly increased in the HAH+ group compared with the HAH- group (25.96 ± 4.97 vs. 24.76 ± 4.76 cm/s, p = 0.045), whereas the Vs and Vm were not significantly different between the two groups. Additionally, the HAH+ patients also exhibited a lower RI and PI in the left VA (p = 0.040 and 0.025, respectively). However, in the right VA, the velocities and pulsate indexes showed no differences between HAH+ group and HAH- one (all p > 0.05, Table 2).

Table 2.

Differences between HAH+ and HAH- groups in demographics, systemic and cerebral hemodynamics (N = 363)

Headachea HAH- HAH+ HAH intensities p (H+ vs. H-)
Cases(n) (90) (273) Mild (215) Moderate (52) Sever (6)
Demographic factors
Age 22.59 ± 3.95 23.60 ± 4.48 23.12 ± 4.26 25.47 ± 4.99 25.00 ± 3.69 0.044*
BMI 21.52 ± 2.11 21.90 ± 2.61 21.85 ± 2.55 21.96 ± 2.89 23.56 ± 2.09 0.199
Smoking(yes) 20(22.2%) 66(24.2%) 52(24.2%) 11(21.2%) 3(50.0%) 0.705
Alcohol consumption(yes) 54(60.0%) 159(58.2%) 126 (58.6%) 28(53.8%) 5(83.3%) 0.796
Systemic hemodynamics
SBP 117.28 ± 11.62 118.66 ± 12.03 118.84 ± 12.38 118.17 ± 11.04 116.67 ± 7.76 0.340
DBP 77.52 ± 10.83 78.86 ± 9.97 78.89 ± 10.21 78.92 ± 9.26 77.33 ± 8.43 0.279
ΔBP 39.76 ± 7.14 39.80 ± 6.59 39.94 ± 7.04 39.25 ± 4.54 39.33 ± 5.24 0.958
MAP 90.77 ± 10.57 92.13 ± 10.24 92.21 ± 10.47 92.01 ± 9.65 90.44 ± 7.83 0.280
HR 84.41 ± 13.11 87.96 ± 13.02 87.35 ± 12.65 89.35 ± 13.26 98.00 ± 20.66 0.026*
SpO2 88.70 ± 2.98 87.94 ± 3.19 88.16 ± 3.01 87.06 ± 3.81 87.83 ± 3.06 0.048*
LA 29.82 ± 2.12 29.70 ± 2.18 29.75 ± 1.99 29.40 ± 2.84 30.33 ± 2.50 0.632
LV 45.78 ± 2.27 46.00 ± 2.25 46.04 ± 2.21 45.85 ± 2.44 45.83 ± 2.32 0.425
RA 33.98 ± 2.04 34.10 ± 2.32 34.14 ± 2.27 34.06 ± 2.56 33.17 ± 2.32 0.661
RV 33.48 ± 2.24 33.70 ± 2.56 33.78 ± 2.56 33.50 ± 2.60 32.50 ± 2.07 0.469
PA 19.83 ± 1.14 19.95 ± 1.42 19.93 ± 1.42 19.98 ± 1.48 20.33 ± 1.03 0.452
EF 66.38 ± 4.28 67.16 ± 4.72 67.29 ± 4.82 66.87 ± 4.40 64.83 ± 3.31 0.165
SV 65.92 ± 8.96 67.32 ± 9.72 67.57 ± 9.79 66.66 ± 9.42 64.17 ± 10.63 0.230
CO 5.16 ± 1.14 5.60 ± 1.02 5.60 ± 1.03 5.65 ± 1.02 5.60 ± .663 0.001**
Tricuspid regurgitation 0.50(0.80) 0.50(0.60) 0.50(0.60) 0.50(0.80) 0.40(0.68) 0.135
Cerebral hemodynamics
Left side MCA
Vm 67.46 ± 12.18 67.41 ± 11.74 66.91 ± 10.87 69.35 ± 14.87 68.50 ± 11.47 0.973
Vs 102.17 ± 14.94 101.41 ± 15.91 100.79 ± 15.15 103.92 ± 18.83 102.00 ± 15.82 0.693
Vd 48.0 ± 10.12 47.96 ± 9.10 47.51 ± 8.37 49.46 ± 11.67 51.00 ± 8.60 0.964
PI 0.820 ± 0.169 0.800 ± 0.130 0.802 ± 0.127 0.799 ± 0.141 0.750 ± 0.130 0.260
RI 0.531 ± 0.063 0.527 ± 0.0490 0.528 ± 0.048 0.526 ± 0.051 0.499 ± 0.057 0.532
Left side VA
Vm 35.18 ± 5.57 36.38 ± 6.19 35.93 ± 5.66 37.63 ± 6.59 41.67 ± 14.40 0.103
Vs 51.28 ± 7.05 52.16 ± 8.49 51.75 ± 7.93 53.19 ± 9.20 57.83 ± 17.59 0.374
Vd 24.76 ± 4.76 25.96 ± 4.97 25.46 ± 4.49 27.35 ± 5.08 32.00 ± 11.93 0.045*
PI 0.765 ± 0.159 0.727 ± 0.153 0.738 ± 0.153 0.690 ± 0.150 0.640 ± 0.102 0.040*
RI 0.517 ± 0.065 0.500 ± 0.061 0.505 ± 0.058 0.482 ± 0.070 0.454 ± 0.053 0.025*
Right side MCA
Vm 63.51 ± 13.67 64.46 ± 11.45 64.24 ± 11.26 64.87 ± 11.57 68.67 ± 17.61 0.518
Vs 95.59 ± 17.61 96.24 ± 15.67 96.17 ± 15.55 96.13 ± 15.65 99.83 ± 22.29 0.740
Vd 45.11 ± 10.96 45.75 ± 8.73 45.53 ± 8.52 46.12 ± 8.95 50.67 ± 13.74 0.573
PI 0.812 ± 0.144 0.792 ± 0.124 0.796 ± 0.121 0.780 ± 0.125 0.734 ± 0.190 0.191
RI 0.530 ± 0.053 0.526 ± 0.051 0.527 ± 0.051 0.521 ± 0.047 0.493 ± 0.076 0.440
Right side VA
Vm 37.27 ± 6.18 37.27 ± 6.02 37.00 ± 5.80 38.63 ± 6.89 35.17 ± 4.66 0.991
Vs 52.51 ± 7.69 52.26 ± 8.29 52.11 ± 8.09 53.42 ± 9.21 47.50 ± 6.06 0.800
Vd 26.72 ± 5.09 26.55 ± 4.74 26.26 ± 4.56 27.75 ± 5.33 26.33 ± 4.89 0.764
PI 0.716 ± 0.208 0.693 ± 0.117 0.702 ± 0.117 0.669 ± .114 0.606 ± 0.056 0.202
RI 0.500 ± 0.119 0.491 ± 0.053 0.494 ± 0.052 0.480 ± .053 0.448 ± 0.037 0.317
BA
Vm 41.42 ± 8.64 44.18 ± 9.74 43.80 ± 9.42 46.33 ± 10.91 38.83 ± 8.06 0.017*
Vs 65.46 ± 11.54 68.81 ± 14.84 68.60 ± 14.32 70.81 ± 16.13 59.17 ± 19.63 0.028*
Vd 28.61 ± 7.46 30.47 ± 7.52 30.07 ± 7.31 32.29 ± 8.31 28.83 ± 6.27 0.042*
PI 0.914 ± 0.224 0.879 ± 0.193 0.890 ± 0.192 0.844 ± 0.183 0.760 ± .262 0.151
RI 0.564 ± 0.078 0.554 ± 0.068 0.559 ± 0.066 0.542 ± 0.069 0.496 ± .086 0.292
Asymmetry of the bilateral VAs
ΔVs −1.00 (8.00) 0. 00 (9.00) 0.00(9.00) 0.00 (10.50) 5.00 (28.5) 0.126
ΔVd −3.00 (6.25) −1.00 (6.00) −1.00(7.00) −1.00 (3.75) 2.00 (18.5) 0.010*
ΔVm −2.50 (8.00) −1.00 (6.00) −1.00(6.00) −1.00 (4.75) 1.00 (23.75) 0.046*
AI% −6.6(22.0) −2.7 (18.0) −2.9(18.4) −2.1(13.8) 2.8 (52.2) 0.040*
Conduction
CVCi 0.729 ± 0.145 0.724 ± 0.140 0.719 ± 0.135 0.737 ± 0.153 0.767 ± 0.191 0.758

*p is 0.05 or less, **p is 0.01 or less

HAH was characterized with higher velocity in posterior cerebral circulation and higher HR but lower SpO2

The asymmetry of the bilateral VAs, including the ΔVd (p = 0.010), ΔVm (p = 0.046) and AI (p = 0.040), in the HAH patients was significantly different than the HAH- subjects. The cerebrovascular conductance index (0.724 ± 0.140 vs.0.729 ± 0.145, respectively, p = 0.758) was similar in the HAH+ and HAH- subjects (Table 2).

The Spearman’s correlation analyses demonstrated that age (r = 0.178, p = 0.001), HR (r = 0.143, p = 0.006) and CO (r = 0.175, p = 0.001) exhibited significantly positive relationships with the HAH severity, whereas the SpO2 (r = −0.148, p = 0.005) exhibited an inverse relationship. The other parameters in systemic hemodynamics were not closely associated with HAH (all p > 0.05). The anterior circulation parameters, including the velocities, PIs and RIs in the bilateral MCA, had no associations with HAH severity. With the exception of the Vs, the other parameters (Vm, Vd, PI and RI) of the BA exhibited significant associations with HAH (p was 0.023, 0.021, 0.045 and 0.042, respectively). On the left side VA, the Vd (r = 0.157, p = 0.003) and Vm (r = 0.120, p = 0.022) exhibited positive relationships with HAH, whereas the PI (r = −0.152, p = 0.004) and RI (r = −0.166, p = 0.001) were negatively correlated with HAH. The parameters on the right side of the VA were not as closely correlated with HAH. Furthermore, associations between VA asymmetries and HAH were also identified in the bilateral VAs: ΔV of Vd (r = 0.137, p = 0.009), ΔV of Vm (r = 0.105, p = 0.046) and AI (r = 0.106, p = 0.043). The relationships between HAH and the hemodynamic parameters are shown in Table 3.

Table 3.

Relationships between HAH and demographic, systemic and cerebral hemodynamic parameters (N = 363)

Headache score
r p r p
Demographic factors PI −0.152 0.004**
Age 0.178 0.001** RI −0.166 0.001**
BMI 0.075 0.155
Right side MCA
Systemic hemodynamics Vm 0.078 0.136
SBP 0.031 0.561 Vs 0.055 0.297
DBP 0.031 0.560 Vd 0.086 0.103
ΔBP 0.009 0.865 PI −0.099 0.059
MAP 0.033 0.535 RI −0.087 0.097
HR 0.143 0.006**
SpO2 −0.148 0.005** Right side VA
LA −0.035 0.507 Vm 0.039 0.455
LV 0.027 0.610 Vs <0.001 0.997
RA 0.010 0.851 Vd 0.036 0.499
RV 0.001 0.992 PI −0.083 0.115
PA 0.058 0.275 RI −0.065 0.215
EF 0.045 0.390
SV 0.035 0.506 BA
CO 0.175 0.001** Vm 0.119 0.023*
Tricuspid regurgitation 0.044 0.400 Vs 0.077 0.141
Vd 0.121 0.021*
Cerebral hemodynamics PI −0.105 0.045*
Left side MCA RI −0.107 0.042*
Vm 0.033 0.536
Vs 0.018 0.733 Asymmetry of VAs
Vd 0.039 0.454 ΔVs 0.080 0.130
PI −0.039 0.458 ΔVd 0.137 0.009**
RI −0.050 0.345 ΔVm 0.105 0.046*
AI% 0.106 0.043*
Left side VA
Vm 0.120 0.022* Conduction
Vs 0.067 0.203 CVCi 0.019 0.716
Vd 0.157 0.003**

*p is 0.05 or less, **p is 0.01 or less

HAH was positively associated with HR, CO and cerebral velocities while it negatively correlated with SpO2, PIs and RIs in BA and left side VA

Risk factors for HAH at 3700 m

Univariate logistic regression was performed for variable with a p < 0.05 in correlation analyses or significant difference between HAH+ and HAH- groups. HR, SpO2, CO, Vd, PI and RI of left side VA, velocities in BA (Vm, Vd) and ΔVd were risk factors for HAH. After adjusted regression analyses, only HR (or CO) and ΔVd were independent risk factors for HAH (Table 4).

Table 4.

Univariate and adjusted logistic regression for variables at 3700 m (N = 363)

Risk factors β-coefficient Odds ratio (95% CI) p value
Lower Upper
Univariate logistic regression
HR 0.022 1.022 1.003 1.042 0.027*
SpO2 −0.081 0.922 0.851 1.000 0.049*
CO 0.422 1.524 1.195 1.944 0.001**
Left VA Vd 0.052 1.053 1.001 1.108 0.046*
PI −1.562 0.210 0.047 0.944 0.042*
RI −4.476 0.011 0.000 0.591 0.026*
BA Vm 0.032 1.033 1.005 1.061 0.018*
Vd 0.044 1.036 1.001 1.071 0.035*
Asymmetry of VAs ΔVd 0.063 1.065 1.011 1.122 0.018*
Adjusted logistic regression
Model 1
HR 0.025 1.025 1.005 1.045 0.012*
Model 2
HR 0.023 1.023 1.003 1.044 0.026*
ΔVd 0.065 1.068 1.013 1.126 0.015*
Model3
CO 0.417 1.517 1.189 1.937 0.001**
ΔVd 0.063 1.065 1.009 1.124 0.022*

*p is 0.05 or less, **p is 0.01 or less

Model 1: Adjusted by primary variables (SpO2, Vd in left side VA and BA);

Model 2: Adjusted by primary variables and an asymmetry data (ΔVd);

Model 3: Avoided the colinearity between HR and CO, indicated that CO and ΔVd were independent risk factors for HAH;

We just listed the variable with a p < 0.05

Associations between hemodynamic parameters and HAH in a subgroup of 129 subjects

In the baseline parameters, CO, Vm, PI and RI in left side VA, velocities [Vm (60.20 ± 10.37 vs. 54.29 ± 7.03 cm/s, p = 0.004), Vs (92.11 ± 14.53 vs. 85.64 ± 10.46 cm/s, p = 0.023) and Vd (41.42 ± 7.60 vs. 37.19 ± 5.50 cm/s, p = 0.005)] in right MCA were significant different between HAH+ and HAH- groups. Furthermore, CO showed a positive relationship with HAH (Table 5).

Table 5.

Associations between baseline parameters and HAH (N = 129)

Differences between HAH+ Correlation with HAH intensities
and HAH- groups
Headache Cases(n) HAH-(31) HAH+(98) p value r p value
Demographic factors
Age 22.71 ± 3.21 23.13 ± 4.31 0.616 0.093 0.297
BMI 21.41 ± 1.67 22.07 ± 2.52 0.175 0.153 0.084
Smoking(yes) 7(22.5%) 23(23.5%) 0.919 / /
Alcohol consumption(yes) 21(67.7%) 58(59.2%) 0.396 / /
Primary headache(yes) 4(12.9%) 23(23.5%) 0.209 / /
Systemic hemodynamic
SBP 118.35 ± 10.81 117.32 ± 12.37 0.676 0.018 0.843
DBP 74.00 ± 9.22 75.18 ± 11.31 0.598 0.059 0.509
ΔBP 44.35 ± 6.47 42.13 ± 6.37 0.094 −0.137 0.122
MAP 88.78 ± 9.29 89.22 ± 11.28 0.843 0.061 0.490
HR 63.32 ± 11.35 64.42 ± 10.10 0.607 0.008 0.930
SpO2 98.35 ± 1.02 98.30 ± 1.10 0.793 0.038 0.670
LA 31.06 ± 1.55 30.87 ± 1.78 0.581 −0.062 0.484
LV 45.81 ± 2.14 46.71 ± 2.50 0.071 0.183 0.037*
RA 35.45 ± 1.98 35.78 ± 2.27 0.478 0.153 0.082
RV 35.29 ± 1.85 35.55 ± 2.13 0.542 0.109 0.217
PA 20.06 ± 1.46 20.30 ± 1.63 0.481 0.094 0.288
EF 62.90 ± 5.98 63.10 ± 5.34 0.865 0.002 0.978
SV 62.53 ± 16.31 66.55 ± 10.61 0.113 0.088 0.322
CO 3.79 ± 1.01 4.33 ± 0.93 0.007** 0.177 0.045*
Tricuspid regurgitation 0.50(1.00) 0.45(1.00) 0.372 −0.030 0.739
Cerebral hemodynamic
Left side MCA
Vm 59.61 ± 8.24 63.24 ± 10.92 0.091 0.060 0.501
Vs 93.48 ± 12.13 97.00 ± 15.21 0.246 0.062 0.488
Vd 40.93 ± 6.20 43.62 ± 8.37 0.102 0.058 0.513
PI 0.889 ± 0.154 0.852 ± 0.125 0.180 −0.004 0.960
RI 0.562 ± 0.051 0.550 ± 0.047 0.221 −0.015 0.862
Left side VA
Vm 30.94 ± 5.25 33.23 ± 4.97 0.029* 0.171 0.053
Vs 49.64 ± 7.11 50.82 ± 7.56 0.444 0.083 0.351
Vd 20.68 ± 4.17 22.26 ± 3.95 0.056 0.142 0.107
PI 0.957 ± 0.193 0.873 ± 0.169 0.022* −0.150 0.090
RI 0.594 ± 0.075 0.561 ± 0.056 0.010* −0.159 0.072
Right side MCA
Vm 54.29 ± 7.03 60.20 ± 10.37 0.004** 0.155 0.080
Vs 85.64 ± 10.46 92.11 ± 14.53 0.023* 0.125 0.157
Vd 37.19 ± 5.50 41.42 ± 7.60 0.005** 0.114 0.200
PI 0.888 ± 0.150 0.855 ± 0.146 0.276 −0.078 0.380
RI 0.574 ± 0.062 0.586 ± 0.053 0.592 −0.093 0.292
Right side VA
Vm 32.77 ± 5.30 34.84 ± 4.40 0.032 0.126 0.155
Vs 49.38 ± 6.88 51.03 ± 6.33 0.220 0.073 0.411
Vd 22.09 ± 4.29 23.64 ± 3.95 0.065 0.110 0.216
PI 0.849 ± 0.160 0.793 ± 0.156 0.086 −0.141 0.110
RI 0.555 ± 0.055 0.534 ± 0.061 0.081 −0.134 0.130
BA
Vm 37.55 ± 7.36 40.50 ± 7.80 0.065 0.154 0.082
Vs 66.29 ± 13.65 68.53 ± 13.87 0.433 0.054 0.546
Vd 23.48 ± 5.08 25.69 ± 5.97 0.066 0.139 0.115
PI 0.964 ± 0.210 0.885 ± 0.197 0.092 −0.104 0.239
RI 0.644 ± 0.055 0.621 ± .0714 0.108 −0.074 0.404
Asymmetry of bilateral VAs
ΔVs 2.0 (15.0) 0.0(9.25) 0.795 0.042 0.634
ΔVd 0.0(6.0) −2.0 (6.0) 0.703 0.017 0.851
ΔVm −2.0 (8.0) −1.0 (7.0) 0.934 0.064 0.468
AI% −0.061 (0.224) −0.034(0.200) 0.815 0.075 0.398
Conduction
CVCi 0.648 ± 0.103 0.704 ± 0.145 0.048* 0.097 0.275

/:binary variables that were not analyzed by Spearman’s correlation

*p is 0.05 or less, **p is 0.01 or less

Univariate logistic regression revealed that CO, Vm in both VAs and velocities in right side MCA were risk factors for HAH. However, adjusted analyses showed that CO (adjusted by Vs and Vd of right side MCA, OR: 1.613, p = 0.036 or adjusted by Vm of right side MCA OR: 1.811, p = 0.024) and Vm in right MCA (OR: 1.066, p = 0.011) or left VA (OR: 1.099, p = 0.035) were still independent predictors for HAH (Table 6).

Table 6.

Univariate and adjusted logistic regression for variables at baseline to predict HAH. (N = 129)

Predictors β-coefficient Odds ratio (95% CI) P value
Lower Upper
Univariate logistic regression
CO 0.650 1.915 1.158 3.168 0.011*
Left side VA Vm 0.095 1.099 1.008 1.198 0.031*
Right side MCA Vm 0.071 1.073 1.021 1.127 0.005**
Vs 0.039 1.040 1.005 1.076 0.026*
Vd 0.087 1.091 1.024 1.161 0.007**
Right side VA Vm 0.099 1.104 1.007 1.211 0.035*
Adjusted logistic regression
Model 1
Left VA Vm 0.094 1.099 1.007 1.199 0.035*
CO 0.478 1.613 1.031 2.522 0.036*
Model 2
Right side MCA Vm 0.064 1.066 1.015 1.121 0.011*
CO 0.594 1.811 1.080 3.036 0.024*

Model 1: Adjusted by primary variables (Vs and Vd of right side MCA)

Model 2: Adjusted by calculated variable (Vm of right side MCA)

Baseline CO was an independent predictor for HAH at 3700 m, whereas, Vm in left VA or right MCA was also independent predictors for HAH in different models

Only the variable with a significant statistically has been listed above

* p is 0.05 or less, ** p is 0.01 or less

Furthermore, in the subgroup analysis, the change in tricuspid regurgitation from sea level to 3700 m was significantly different between the HAH+ and HAH- groups. The alterations of ΔV in Vd and Vs of the VAs and the Vm and Vd of the BA were also significantly different between the HAH+ and HAH- groups (see Additional file 1: Table S1A).

Discussion

Alterations in both systemic and cerebral hemodynamics

In the current study, we identified alterations in both systemic and cerebral hemodynamics. The HR dramatically increased between sea level and high altitudes, which is consistent with a previous study that reported a significant increase in HR after exposure to high altitude because of the activation of the parasympathetic nervous system by hypobaric hypoxic stress [15, 4, 16]. However, the SV was similar at both altitudes, which indicates the increased CO was primarily caused by the increased HR [16]. Conversely, the hypoxia also induced a reduction in the SpO2, which may result in a decrease in the delivery of oxygen and energy to organs and tissues. Furthermore, the diastolic function of the heart has been reported to decrease in high altitude environments, which may be because of the shortened cardiac diastolic phase caused by the increased HR [17, 16].

Following acute hypoxic stress, parasympathetic nervous system activation, combined with a disequilibrium in the synthesis and expression of certain vasoconstrictors and vasodilators, results in endothelial cell dysfunction (e.g., increased endothelin-1 expression vs. decreased nitric oxide level) [18, 19]. Therefore, the vasoconstriction of systemic and cerebral arteries exhibits a significant impact on the measured velocities of blood flow [20]. We demonstrated that most velocities in both the anterior and posterior cerebral circulations significantly increased. These results are similar to previous studies in which cerebral blood flow increased dramatically after high altitude exposure [2123].

Associations between HAH occurrence and demographical data

As previously reported by our team and other researchers, HAH patients are typically older in age, which is consistent with the risk factors of primary headache at sea level and high altitude [8, 9]. Although a history of smoking and alcohol consumption did not exhibit associations with HAH, they were not precisely measured, which could be improved in future studies.

HAH is partially associated with systemic hemodynamics

HAH is a regional symptom that comprises the primary diagnostic criteria of acute mountain sickness, which is typically induced by a local and systematic factor [5, 24]. Therefore, systemic hemodynamics may be a cause of HAH because it functions to deliver blood to all organs, including the brain, which is an organ with considerably high metabolism and energy consumption. First, an increased HR exhibited a strongly positive correlation with HAH, which is consistent with the relationship between CO and HAH. The HAH patients were also characterized by increased HR and CO. Further analyses indicated that baseline CO and LV were correlated with HAH significantly. These results may be because of the nervous system changes that lead to alterations in systemic hemodynamics [19, 25, 16]. In addition, the SpO2 was inversely correlated with HAH; however, the SBP and DBP were not related to HAH, which was similar to previous studies [8, 15, 25]. A reduced SpO2 and increased HR are independent risk factors for HAH [8, 9]. These changes could result from sympathetic nervous system activation and a decreased partial pressure of oxygen, which results in a decrease in oxygen delivery to the brain, where oxygen consumption is increased during hypoxic stress [5, 9, 6]. The change in tricuspid regurgitation in HAH patients differed from the non-HAH subjects, which indicates alterations in cardiac function induced by hypoxia may be risk factors for HAH (see Additional file 1).

Cerebral hemodynamic characteristics of HAH

In the present study, we demonstrated that the velocities in both the BA and left VA in the posterior cerebral circulation were strongly associated with HAH, which is partly consistent with previous reports [26, 22, 27]. The HAH patients were characterized by an increased Vd but decreased RI and PI in the left VA. These findings imply that HAH is associated with higher blood flow but lower resistance and compliance. At the baseline, HAH+ patients were also featured with a higher Vm in VAs on both sides indicating that posterior circulation plays critical roles in HAH or it is a pathophysiological process of HAH. Furthermore, the HAH+ group also exhibited increased Vs and Vd in the BA, which supplies blood and oxygen to the cerebellum. These results are consistent with the clinical characteristics that HAH often presents (i.e., a pulsing headache), which may be caused by diastolic dysfunction in the arteries [5, 6]. The relationship between HAH and posterior, rather than anterior, cerebral circulation contributed to HAH occurrence.

Of note, velocities in right MCA at baseline in HAH+ group were differed significantly from those in HAH- group. In partial agreement with the results reported for acute mountain sickness, including HAH, we did not identify an association between HAH and anterior circulation as assessed by the velocities, PI and RI of the bilateral MCAs [28]. However, these results were inconsistent with the previously reported that acute mountain sickness related headache usually presents as frontal headache [5]. The inconsistence may be caused by the sample size in the subgroup of 129 participants.

Though the baseline conduction from systemic to cerebral blood flow, which was evaluated using the cerebrovascular conductance index, showed a significant difference between HAH+ and HAH- groups, it is not predictor for HAH. Furthermore, it was not associated with HAH at 3700 m, which indicates cerebral blood flow plays a primary role in HAH and has more critical importance than systemic hemodynamics.

Predictors and risk factors for HAH

After adjusted regression analyses at baseline, we identified that CO and Vm in left VA (or right MCA in different regressions) were independent predictors for HAH. However, the posterior and anterior circulations were not valuable in a same model.

Other adjusted analyses at 3700 m revealed that only HR (or CO) and ΔVd were independent risk factors for HAH, which is partly consistent with our and others’ previous studies. However, ΔVd was found to be a novel risk factor for HAH which may be caused by the hypoxia induced local expressions of vasoactive substances. Furthermore, the variation in VAs of Chinese Han in anatomy may also be a reason for our findings.

Relationship between HAH and VA asymmetry

We report a novel finding in that VA asymmetry was closely related to HAH. An asymmetry in the bilateral isonym VA exists under normal physiological conditions [21, 28, 29]. However, this physiological asymmetry could become a considerable or pathological irregularity because of its amplification by hypoxia-induced vasodilatation and an impaired auto-regulation of cerebral blood flow following acute high-altitude exposure [21].

Furthermore, HAH severity was closely associated with the VA asymmetry, which represents a characteristic that has not been previously reported. This finding may be associated with the region of blood flow and perfusion in the cortex and cerebellum. It may also be related to the clinical characteristics of the migraine pattern present in many HAH patients [5]. The variance between the isonym VAs may contribute to the development of HAH and requires further examination to identify its precise pathophysiological mechanisms.

HAH comprises multifactorial components [30, 12, 31, 14]. Therefore, the cerebral and systemic hemodynamic characteristics of HAH may be relevant to the disease development, as well as its pathophysiological processes and clinical manifestations.

Limitations

Our study was restricted to young Chinese men, which could potentially generate a bias regarding age or gender; thus, this issue should be addressed in future studies. Another limitation is that a key modulator of cerebral perfusion, partial pressure of carbon dioxide (PaCO2), was not measured in the present study. This modulator could be included in future mechanistic studies. Another limitation is that headache satisfied the diagnostic criteria of the International Classification of Headache Disorders basically. Although the descent was not performed immediately after the onset of the headache, cephalalgia almost resolved as time went on. Furthermore, the subjects were all newcomers from sea level, thus none of them with a history of HAH or acute mountain sickness history, which should be improved in future study.

Conclusions

HAH is characterized, in part, by increased systemic hemodynamics and posterior cerebral circulation as reflected by the velocities in the BA and left VA, as well as lower arterial resistance and compliance. Furthermore, baseline CO and Vm in left VA or right MCA at sea level are independent predictors for HAH, whilst bilateral VA asymmetry may contribute to the development of HAH at high-altitude.

Acknowledgements

This work was supported by the Ministry of Health of the P.R. China [Grant No. 201002012]. We would like to thank all individuals who participated in this study for their support. We are grateful to professor Xia Zhang, Mr. Can Chen, Mr. Bai-Da Xu and Miss Shuang-Fei Li for their helps. We also thank Mr. Ru-Fu Xu for his suggestions regarding the statistical analyses.

Abbreviations

BA

Basilar artery

CO

Cardiac output

DBP

Diastolic blood pressure

EF

Ejection fraction

HAH

High-altitude headache

HAH+

HAH positive or with HAH

HAH-

HAH negative or without HAH

HR

Heart rate

LA

End-diastolic internal diameters of left atrium

LV

End-diastolic internal diameters of left ventricle

MCA

Middle cerebral artery

PA

End-diastolic internal diameters of pulmonary artery

PI

Pulsatility index

RA

End-diastolic internal diameters of right atrium

RI

Resistance index

RV

End-diastolic internal diameters of right ventricle

SBP

Systolic blood pressure

SpO2

Saturation pulse oxygen

SV

Stroke volume

VA

Vertebral artery

Vd

Diastolic velocity

Vm

Mean velocity

Vs

Systolic velocity

ΔVd

Difference in diastolic velocity between bilateral isonym cerebral arteries

ΔVm

Difference in mean velocity between bilateral isonym cerebral arteries

ΔVs

Difference in systolic velocity between bilateral isonym cerebral arteries

Additional file

Additional file 1: Table S1A. (37.5KB, doc)

Associations between changes of hemodymics and HAH in the subgroup.

Footnotes

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

SZB and LH participated the design of this research. SZB also has drafted the manuscript and performed the statistical analysis. JJ, XHZ and JQ have reviewed and revised this manuscript critically for important intellectual content. JY, XHZ, JQ and SZB carried out the filling of case report form and the measurements of blood pressure, HR and SpO2. RSR and SYY carried out the echocardiography examinations. The transcranial Doppler examinations were performed by CFT and QNL. All authors read and approved the final manuscript.

Authors’ information

SZB, MD, Physician and instructor from Institute of Cardiovascular Diseases of PLA; Department of Cardiology, Xinqiao Hospital, Third Military Medical University. His research areas include cardiovascular diseases, acute mountain sickness and high altitude headache and he has published two articles in Journal of headache and pain and European journal of Applied Physiology [8, 28].

LH, PhD, MD, FACC; Professor and Director of Institute of Cardiovascular Diseases of PLA; Department of Cardiology, Xinqiao Hospital, Third Military Medical University. His interests focus on basic and clinical researches in cardiovascular diseases, acute mountain sickness and high altitude headache.

Contributor Information

Shi-Zhu Bian, Phone: +86-23-68755601, Email: bianshizhu@163.com.

Jun Jin, Email: jjxqyy@163.com.

Qian-Ning Li, Email: LLQQNN@hotmail.com.

Jie Yu, Email: simpls@163.com.

Cai-Fa Tang, Email: tangcaifaxinqiao@163.com.

Rong-Sheng Rao, Email: rrs5103@163.com.

Shi-Yong Yu, Email: doctoryushiyong@126.com.

Xiao-Hui Zhao, Email: zxhwn@tmmu.edu.cn.

Jun Qin, Email: qinjunxq@126.com.

Lan Huang, Email: huanglan260@126.com.

References

  • 1.Serrano-Duenas M. High-altitude headache. Expert Rev Neurother. 2007;7:245–248. doi: 10.1586/14737175.7.3.245. [DOI] [PubMed] [Google Scholar]
  • 2.Burtscher M. High altitude headache: epidemiology, pathophysiology, therapy and prophylaxis. Wien Klin Wochenschr. 1999;111:830–836. [PubMed] [Google Scholar]
  • 3.Carod-Artal FJ, High-altitude headache and acute mountain sickness High-altitude headache and acute mountain sickness. Neurologia (Barcelona, Spain) 2014;29(9):533–540. doi: 10.1016/j.nrl.2012.04.015. [DOI] [PubMed] [Google Scholar]
  • 4.Imray C, Wright A, Subudhi A, Roach R. Acute mountain sickness: pathophysiology, prevention, and treatment. Prog Cardiovasc Dis. 2010;52:467–484. doi: 10.1016/j.pcad.2010.02.003. [DOI] [PubMed] [Google Scholar]
  • 5.Alizadeh R, Ziaee V, Aghsaeifard Z, Mehrabi F, Ahmadinejad T. Characteristics of headache at altitude among trekkers; a comparison between acute mountain sickness and Non-acute mountain sickness headache. Asian J Sports Med. 2012;3:126–130. doi: 10.5812/asjsm.34714. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Silber E, Sonnenberg P, Collier DJ, Pollard AJ, Murdoch DR, Goadsby PJ. Clinical features of headache at altitude a prospective study. NEUROLOGY. 2003;60:1167–1171. doi: 10.1212/01.WNL.0000055876.26737.B9. [DOI] [PubMed] [Google Scholar]
  • 7.Lawley JS. Identifying the possible risk factors for high-altitude headache in mountaineers. Cephalalgia. 2011;31:1677–1678. doi: 10.1177/0333102411422385. [DOI] [PubMed] [Google Scholar]
  • 8.Bian SZ, Zhang JH, Gao XB, Li M, Yu J, Liu X, et al. Risk factors for high-altitude headache upon acute high-altitude exposure at 3700 m in young Chinese men: a cohort study. J Headache Pain. 2013;14:35. doi: 10.1186/1129-2377-14-35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Burtscher M, Mairer K, Wille M, Broessner G. Risk factors for high-altitude headache in mountaineers. Cephalalgia. 2011;31:706–711. doi: 10.1177/0333102410394678. [DOI] [PubMed] [Google Scholar]
  • 10.Harris NS, Wenzel RP, Thomas SH. High altitude headache: efficacy of acetaminophen vs. ibuprofen in a randomized, controlled trial. J Emerg Med. 2003;24:383–387. doi: 10.1016/S0736-4679(03)00034-9. [DOI] [PubMed] [Google Scholar]
  • 11.Mampreso E, Maggioni F, Viaro F, Disco C, Zanchin G. Efficacy of oxygen inhalation in sumatriptan refractory "high altitude" cluster headache attacks. J Headache Pain. 2009;10:465–467. doi: 10.1007/s10194-009-0160-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Carod-Artal FJ. High-altitude headache and acute mountain sickness. Neurologia. 2012;29(9):533–540. doi: 10.1016/j.nrl.2012.04.015. [DOI] [PubMed] [Google Scholar]
  • 13.Sanchez del Rio M, Moskowitz MA. High altitude headache. Lessons from headaches at sea level. Adv Exp Med Biol. 1999;474:145–153. doi: 10.1007/978-1-4615-4711-2_13. [DOI] [PubMed] [Google Scholar]
  • 14.Serrano-Duenas M. High altitude headache. A prospective study of its clinical characteristics. Cephalalgia. 2005;25:1110–1116. doi: 10.1111/j.1468-2982.2005.00968.x. [DOI] [PubMed] [Google Scholar]
  • 15.Huang H-H, Tseng C-Y, Fan J-S, Yen DH-T, Kao W-F, Chang S-C, et al. Alternations of heart rate variability at lower altitude in the predication of trekkers with acute mountain sickness at high altitude. Clin J Sport Med. 2010;20:58–63. doi: 10.1097/JSM.0b013e3181cae6ba. [DOI] [PubMed] [Google Scholar]
  • 16.Naeije R. Physiological adaptation of the cardiovascular system to high altitude. Prog Cardiovasc Dis. 2010;52:456–466. doi: 10.1016/j.pcad.2010.03.004. [DOI] [PubMed] [Google Scholar]
  • 17.Bartsch P, Swenson ER. Acute high-altitude illnesses. N Engl J Med. 2013;369:1666–1667. doi: 10.1056/NEJMc1309747. [DOI] [PubMed] [Google Scholar]
  • 18.Bailey DM, Roukens R, Knauth M, Kallenberg K, Christ S, Mohr A, et al. Free radical-mediated damage to barrier function is not associated with altered brain morphology in high-altitude headache. J Cereb Blood Flow Metab. 2006;26:99–111. doi: 10.1038/sj.jcbfm.9600169. [DOI] [PubMed] [Google Scholar]
  • 19.Boushel R, Calbet JA, Radegran G, Sondergaard H, Wagner PD, Saltin B. Parasympathetic neural activity accounts for the lowering of exercise heart rate at high altitude. Circulation. 2001;104:1785–1791. doi: 10.1161/hc4001.097040. [DOI] [PubMed] [Google Scholar]
  • 20.Jansen GF, Krins A, Basnyat B. Cerebral vasomotor reactivity at high altitude in humans. J Appl Physiol (Bethesda, Md : 1985) . 1999;86:681–686. doi: 10.1152/jappl.1999.86.2.681. [DOI] [PubMed] [Google Scholar]
  • 21.Ainslie PN, Subudhi AW. Cerebral blood flow at high altitude. High Alt Med Biol. 2014;15:133–140. doi: 10.1089/ham.2013.1138. [DOI] [PubMed] [Google Scholar]
  • 22.Lucas SJE, Burgess KR, Thomas KN, Donnelly J, Peebles KC, Lucas RAI, et al. Alterations in cerebral blood flow and cerebrovascular reactivity during 14 days at 5050 m. J Physiol. 2011;589:741–753. doi: 10.1113/jphysiol.2010.192534. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Norcliffe LJ, Rivera-Ch M, Claydon VE, Moore JP, Leon-Velarde F, Appenzeller O, et al. Cerebrovascular responses to hypoxia and hypocapnia in high-altitude dwellers. J Physiol. 2005;566:287–294. doi: 10.1113/jphysiol.2005.086629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Willie CK, Smith KJ, Day TA, Ray LA, Lewis NCS, Bakker A, et al. Regional cerebral blood flow in humans at high altitude: gradual ascent and 2 wk at 5,050 m. J Appl Physiol (Bethesda, Md : 1985) 2014;116:905–910. doi: 10.1152/japplphysiol.00594.2013. [DOI] [PubMed] [Google Scholar]
  • 25.Koehle MS, Guenette JA, Warburton DER. Oximetry, heart rate variability, and the diagnosis of mild-to-moderate acute mountain sickness. Eur J Emerg Med: official journal of the European Society for Emergency Medicine. 2010;17:119–122. doi: 10.1097/MEJ.0b013e32832fa099. [DOI] [PubMed] [Google Scholar]
  • 26.Baumgartner RW, Spyridopoulos I, Bartsch P, Maggiorini M, Oelz O. Acute mountain sickness is not related to cerebral blood flow: a decompression chamber study. J Appl Physiol (1985) 1999;86:1578–1582. doi: 10.1152/jappl.1999.86.5.1578. [DOI] [PubMed] [Google Scholar]
  • 27.Birmingham Medical Research Expeditionary S, Caudwell Xtreme Everest Research G. Wilson MH, Davagnanam I, Holland G, Dattani RS, Tamm A, Hirani SP, Kolfschoten N, Strycharczuk L, Green C, Thornton JS, Wright A, Edsell M, Kitchen ND, Sharp DJ, Ham TE, Murray A, Holloway CJ, Clarke K, Grocott MPW, Montgomery H, Imray C, Ahuja V, Aref-Adib G, Burnham R, Chisholm A, Clarke K, Coates D, Coates M, et al. Cerebral venous system and anatomical predisposition to high-altitude headache. Ann Neurol. 2013;73:381–389. doi: 10.1002/ana.23796. [DOI] [PubMed] [Google Scholar]
  • 28.Bian SZ, Jin J, Li QN, Qin J, Zhang JH, Yu SY, Chen JF, Tang CF, Huang L. Cerebral hemodynamic characteristics of acute mountain sickness upon acute high-altitude exposure at 3,700 m in young Chinese men. European journal of applied physiology. 2014;114(10):2193–2200. doi: 10.1007/s00421-014-2934-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Wolff CB. Cerebral blood flow and oxygen delivery at high altitude. High Alt Med Biol. 2000;1:33–38. doi: 10.1089/152702900320667. [DOI] [PubMed] [Google Scholar]
  • 30.Batsis JA, Phy MP. Intracranial hypotension: aggravation of headache at high altitude. Headache. 2005;45:380–384. doi: 10.1111/j.1526-4610.2005.05077_2.x. [DOI] [PubMed] [Google Scholar]
  • 31.Miller JA, Gray J. Migraines and high-altitude headaches. Wilderness Environ Med. 2003;14:286–287. doi: 10.1580/1080-6032(2003)14[286:LTTE]2.0.CO;2. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Headache and Pain are provided here courtesy of BMC

RESOURCES